| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |